ArticleCureus2024
Risperidone-Induced Urinary Incontinence in Schizoaffective Disorder: A Case Report.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Risperidone is a widely used atypical antipsychotic known for its efficacy in managing various psychiatric conditions. However, it is not without adverse effects, and one such underreported side effect is that of urinary incontinence. This case report highlights the experience of a 59-year-old gentleman with a diagnosis of schizoaffective disorder who, after being admitted due to a relapse of his symptoms, developed urinary incontinence with risperidone. The patient's symptoms resolved upon the gradual reduction of the risperidone dose to 2 mg at bedtime. Urinary incontinence as a side effect of antipsychotics has been documented in children, especially in those with autism or developmental disorders, but there is limited research on its occurrence in adults. Urinary incontinence can have significant social and psychological impacts on patients, leading to feelings of embarrassment and social withdrawal. It can also contribute to treatment non-adherence leading to frequent relapses and exacerbations of psychiatric symptoms. In managing patients with risperidone-induced urinary incontinence, it is essential to explore medical causes thoroughly before considering medication changes. Behavioral modifications such as bladder training, biofeedback, and lifestyle modifications can also be effective in reducing the frequency of incontinence episodes. This case report emphasizes the importance of prompt identification and intervention to minimize the debilitating effects of urinary incontinence on patients with psychiatric conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.